triazoles has been researched along with Cryptosporidiosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Allaie, IM; Garcia Hernandez, A; Grooms, GM; Khan, SM; Li, K; Stec, J; Witola, WH | 1 |
Benjamin, NN; Cuny, GD; Gollapalli, DR; Hedstrom, L; Johnson, CR; Kirubakaran, S; Maurya, SK; Zhang, M | 1 |
Cooper, S | 1 |
3 other study(ies) available for triazoles and Cryptosporidiosis
Article | Year |
---|---|
Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum.
Topics: Animals; Antiprotozoal Agents; Child; Child, Preschool; Cryptosporidiosis; Cryptosporidium; Cryptosporidium parvum; Humans; Indoles; Toxoplasma; Toxoplasmosis; Triazoles | 2022 |
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Enzyme Inhibitors; IMP Dehydrogenase; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2009 |
NTZ for cryptosporidiosis: larger expanded access; buyers' club/FDA conflict. Food and Drug Administration.
Topics: Altruism; Clinical Trials as Topic; Consumer Organizations; Cryptosporidiosis; Drug Industry; Drugs, Investigational; Health Services Accessibility; Humans; Nitro Compounds; Thiazoles; Triazoles; United States; United States Food and Drug Administration | 1996 |